Hansoh Pharmaceutical Group Co (HKSE:03692) Other Current Liabilities : HK$1,734 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Other Current Liabilities?

Hansoh Pharmaceutical Group Co's other current liabilities for the quarter that ended in Dec. 2023 was HK$1,734 Mil.

Hansoh Pharmaceutical Group Co's quarterly other current liabilities declined from Dec. 2022 (HK$1,812 Mil) to Jun. 2023 (HK$1,709 Mil) but then increased from Jun. 2023 (HK$1,709 Mil) to Dec. 2023 (HK$1,734 Mil).

Hansoh Pharmaceutical Group Co's annual other current liabilities declined from Dec. 2021 (HK$2,139 Mil) to Dec. 2022 (HK$1,812 Mil) and declined from Dec. 2022 (HK$1,812 Mil) to Dec. 2023 (HK$1,734 Mil).

Hansoh Pharmaceutical Group Co Other Current Liabilities Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Other Current Liabilities Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Hansoh Pharmaceutical Group Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Hansoh Pharmaceutical Group Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Other Current Liabilities

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Executives

Cen Junda	2307 Founder of a discretionary trust who can infl
Cantrust (far East) Limited	2301 Trustee
Jqc Holding Limited	2201 Interest of corporation controlled by you
Jqc International Limited	2201 Interest of corporation controlled by you
Sun Yuan	2101 Beneficial owner
Harmonia Holding Investing (ptc) Limited	2201 Interest of corporation controlled by you
Stellar Infinity Company Ltd.	2101 Beneficial owner
Sunrise Investment Advisors Limited	2201 Interest of corporation controlled by you
Zhong Huijuan	2307 Founder of a discretionary trust who can infl
Apex Medical Company Ltd.	2101 Beneficial owner

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines